{"id":"NCT00009737","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer","officialTitle":"An Open-Label Randomized Phase III Study Comparing Xeloda (Capecitabine) With IV Bolus 5-Fluorouracil in Combination With Low-Dose Leucovorin as Adjuvant Chemotherapy in Patients Who Underwent Surgery for Dukes C Colon Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1998-11","primaryCompletion":"2004-04","completion":"2004-04","firstPosted":"2004-03-17","resultsPosted":"2016-06-22","lastUpdate":"2016-06-22"},"enrollment":1987,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Colorectal Cancer"],"interventions":[{"type":"DRUG","name":"5-Fluorouracil","otherNames":[]},{"type":"DRUG","name":"Leucovorin","otherNames":[]},{"type":"DRUG","name":"Capecitabine [Xeloda]","otherNames":[]}],"arms":[{"label":"Capecitabine","type":"EXPERIMENTAL"},{"label":"5-Fluorouracil + Leucovorin","type":"ACTIVE_COMPARATOR"}],"summary":"This 2 arm study will compare the safety and efficacy of oral Xeloda, or 5-fluorouracil in combination with leucovorin, in patients who have undergone surgery for colon cancer. Patients will be randomized to receive either Xeloda 1250mg/m2 po bid on days 1-14 every 21 days, or leucovorin 20mg/m2 iv + 5-fluorouracil 425mg/m2 iv daily from day 1 to day 5 every 28 days. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.","primaryOutcome":{"measure":"Disease-free Survival","timeFrame":"Approximately 3 years","effectByArm":[{"arm":"Capecitabine","deltaMin":656,"sd":null},{"arm":"5-Fluorouracil + Leucovorin","deltaMin":603,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.053"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":133,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","Germany","Israel","Italy","Portugal","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":181,"n":995},"commonTop":["Diarrhoea","Nausea","Stomatitis all","Palmar-plantar","Vomiting"]}}